ParaTechs

Executive Summary

ParaTechs Corporation is a privately held biotechnology company that develops and commercializes innovative tools for biomedical research, with a focus on rodent assisted reproduction and recombinant protein expression. Founded in 1990 and headquartered in Corvallis, Oregon, the company's core offerings include non-surgical embryo transfer (NSET) devices, artificial insemination tools, and the VE-BEVS protein expression system. These products address critical needs in transgenic animal model creation and recombinant protein production, enabling researchers to accelerate drug discovery and development. ParaTechs operates through a hybrid model of product sales and contract research services, providing both standardized tools and customized solutions to academic and industrial customers. Despite being a small player relative to larger life science tool providers, ParaTechs has established a niche by offering specialized, high-quality solutions for rodent reproduction and protein expression, supported by decades of expertise in the field. The company's long-standing presence since 1990 suggests resilience and steady demand for its unique offerings, though growth has likely been modest given the private, non-venture-backed profile.

Upcoming Catalysts (preview)

• Q4 2026Launch of Next-Generation NSET Device60% success
• H1 2027Strategic Partnership for VE-BEVS Commercialization45% success
• TBDExpansion into Companion Animal Reproductive Services30% success